JP MORGAN/PUT/PFIZER INC/42/0.1/17.01.25 | Delayed Börse Stuttgart 02:59:27 2024-07-17 am EDT | ||
| 1.19 EUR | -1.65% |
|
| Current month | -10.37% | ||
| 1 month | -10.37% |
Comparison chart between the derivative product and it's underlying value
End-of-day quotes
Chart
PFIZER, INC.
Latest news about PFIZER, INC.
More news
| Date | Price | Change |
|---|---|---|
| 24-07-17 | 1.19 | -1.65% |
| 24-07-16 | 1.21 | -0.82% |
| 24-07-15 | 1.22 | -2.40% |
| 24-07-12 | 1.25 | -3.10% |
| 24-07-11 | 1.29 | -3.73% |
Delayed Quote Börse Stuttgart
Last update July 17, 2024 at 02:59 am EDT
More quotesStatic data
| Product type | Warrant Plain-Vanilla |
|---|---|
| Buy / Sell | PUT |
| Underlying | PFIZER, INC. |
| Issuer | J.P. Morgan |
| WKN | JS4RGW |
| ISIN | DE000JS4RGW5 |
| Date issued | 2022-12-29 |
| Strike | 42 $ |
| Maturity | 2025-01-17 (184 Days) |
| Parity | 10 : 1 |
| Emission price | 0.36 € |
| Emission volume | N/A |
| Settlement | cash |
| Currency | EUR |
Technical Indicators
| Highest since issue | 1.59 € |
|---|---|
| Lowest since issue | 0.38 € |
Company Profile
Pfizer, Inc. is the world's leading pharmaceutical group. Net sales break down by family of products as follows:
- primary care products (72.8%): medicines used in internal medicine, vaccines, medicines for the prevention and treatment of Covid-19, antivirals, mRNA-based products, etc.;
- specialty care products (13.8%): medicines used in immunology, in hospitals and for the treatment of rare diseases, anti-inflammatory medicines, etc.;
- oncology products (12.1%);
- other (1.3%).
At the end of 2022, the group had more than 35 manufacturing sites worldwide.
Net sales are distributed geographically as follows: the United States (42.3%), Europe (21.9%) and other (35.8%).
Sector
-
Consensus: Pfizer, Inc.
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
24
Last Close Price
29.5
USD
Average target price
32.1
USD
Spread / Average Target
+8.80%
- Stock Market
- Warrants
- Warrant
